Lidocaina Cloridrato Fisiopharma

Lidocaine Hydrochloride, the active ingredient in Lidocaina Cloridrato Fisiopharma, is a local anesthetic presented as a sterile solution for infiltration and perineural use. It provides reversible nerve impulse blockade for minor surgical and diagnostic procedures in adult patients. GNH USA supplies Lidocaina Cloridrato Fisiopharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Hydrochloride acts on peripheral nerve membranes to produce temporary loss of sensation in targeted areas. - Infiltration procedures: provides localized numbness for minor surgical or diagnostic interventions. - Peripheral nerve block: enables perineural anesthesia for limb or regional surgeries. - Minor surgical procedures: supplies rapid, controllable analgesia for suturing, biopsies, and dental work.

Lidocaine Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Burning or stinging at the injection site - Tingling or numbness extending beyond the target area - Redness or mild swelling at the site - Dizziness or light‑headedness - Nausea or mild headache

Serious or Rare Side Effects: - Central nervous system toxicity (seizures, loss of consciousness) - Cardiovascular effects (arrhythmias, hypotension, cardiac arrest) - Methemoglobinemia - Severe allergic reactions (anaphylaxis, angioedema) - Respiratory depression - Persistent neurologic deficits (rare).

Before using Lidocaina Cloridrato Fisiopharma, clinicians should consider several safety measures. - Allergy assessment: confirm no known hypersensitivity to amide‑type local anesthetics. - Cardiac monitoring: observe patients with pre‑existing heart disease or arrhythmias. - Dose limitation: avoid exceeding recommended maximum cumulative dose for the procedure. - Concomitant CNS depressants: use caution when combined with other agents that depress the central nervous system. - Pediatric use: adjust dose carefully based on weight and clinical judgment. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Lidocaine may interact with other medications, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): increased risk of cardiotoxicity. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise systemic lidocaine levels. - Beta‑blockers: can potentiate bradycardia and hypotension.

Moderate Interactions (Monitor Closely): - General anesthetics (e.g., propofol, volatile agents): additive central nervous system depression. - Diuretics (e.g., furosemide): may affect plasma concentration of lidocaine. - Other local anesthetics: cumulative toxicity risk when used together.